Table 1.
Clinical and Imaging Characteristics of 59 Cases of Angiocentric Gliomas.
| Groups | Number | Percentage | |
|---|---|---|---|
| Age at surgery (years) | Children (0–6) | 16 | 27.12% |
| Juveniles (7–17) | 27 | 45.76% | |
| Young adults (18–46) | 12 | 20.34% | |
| Middle adults (45–59) | 3 | 5.08% | |
| Elderly (>60) | 1 | 1.69% | |
| Symptoms | Epilepsy | 45 | 76.27% |
| Headache and dizziness alone | 4 | 6.78% | |
| Vision and hearing loss | 4 | 6.78% | |
| Epilepsy with headache | 3 | 5.08% | |
| Developmental delay | 2 | 3.39% | |
| Auditory hallucinations | 1 | 1.69% | |
| Location | Temporal lobe | 22 | 37.29% |
| Frontal lobe | 17 | 28.81% | |
| Parietal lobe | 7 | 11.86% | |
| Occipitoparietal lobe | 4 | 6.78% | |
| Frontotemporal lobe | 2 | 3.39% | |
| Frontoparietal lobe | 2 | 3.39% | |
| Temporo-parietal lobe | 1 | 1.69% | |
| Occipital lobe | 1 | 1.69% | |
| Insular lobe | 1 | 1.69% | |
| Midbrain | 1 | 1.69% | |
| Thalamus | 1 | 1.69% | |
| Solid/Cystic | Solid | 54 | 91.53% |
| Cystic | 5 | 8.47% | |
| Contrast-enhancement | No enhancement | 40 | 40/47, 85.11% |
| Slightly enhancement | 5 | 5/47, 10.64% | |
| Significant enhancement | 2 | 2/47, 4.26% | |
| Not available | 12 | - |